Methods for treating disease and forming a supplemented...

Details Methods for treating disease and forming a supplemented... Methods for treating disease and forming a supplemented...

2007-04-24

2007-04-24

Witz, Jean C. (Department: 1651)

Drug, bio-affecting and body treating compositions

Extract, body fluid, or cellular material of undetermined...

Derived from musculoskeletal system, other than cardiac muscle

C424S529000, C424S530000, C514S002600, C514S021800

Reexamination Certificate

active

08485898

ABSTRACT:
This invention provides supplemented and unsupplemented tissue sealants as well as methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one oligonucleotide. The composition may be further supplemented with, for example, one or more analgesics, antimicrobial compositions, anticoagulants, antiproliferatives, anti-inflammatory compounds, cytokines, cytotoxins, drugs, growth factors, interferons, hormones, lipids, demineralized bone or bone morphogenetic proteins, cartilage inducing factors, oligonucleotides polymers, polysaccharides, polypeptides, protease inhibitors, vasoconstrictors or vasodilators, vitamins, minerals, stabilizers and the like.

REFERENCES:
patent: 2533004 (1950-12-01), Ferry et al.
patent: 3523807 (1970-08-01), Gerendas
patent: 3723244 (1973-03-01), Breillatt, Jr.
patent: 4265233 (1981-05-01), Sugitachi et al.
patent: 4298598 (1981-11-01), Schwarz et al.
patent: 4321711 (1982-03-01), Mano
patent: 4359049 (1982-11-01), Redl et al.
patent: 4362567 (1982-12-01), Schwarz et al.
patent: 4373519 (1983-02-01), Errede et al.
patent: 4377572 (1983-03-01), Schwarz et al.
patent: 4394370 (1983-07-01), Jefferies
patent: 4414976 (1983-11-01), Schwarz et al.
patent: 4427650 (1984-01-01), Stroetmann
patent: 4427651 (1984-01-01), Stroetmann
patent: 4442655 (1984-04-01), Stroetmann
patent: 4453939 (1984-06-01), Zimmerman et al.
patent: 4472840 (1984-09-01), Jefferies
patent: 4516276 (1985-05-01), Mittelmeier et al.
patent: 4600574 (1986-07-01), Lindner et al.
patent: 4617293 (1986-10-01), Wahlig et al.
patent: 4619913 (1986-10-01), Luck et al.
patent: 4619989 (1986-10-01), Urist
patent: 4627879 (1986-12-01), Rose et al.
patent: 4631055 (1986-12-01), Redl et al.
patent: 4642120 (1987-02-01), Nevo et al.
patent: 4714457 (1987-12-01), Alterbaum
patent: 4717717 (1988-01-01), Finkenaur
patent: 4761471 (1988-08-01), Urist
patent: 4789732 (1988-12-01), Urist
patent: 4816339 (1989-03-01), Tu et al.
patent: 4820626 (1989-04-01), Williams et al.
patent: 4837379 (1989-06-01), Weinberg
patent: 4861757 (1989-08-01), Antoniades et al.
patent: 4874746 (1989-10-01), Antoniades et al.
patent: 4904259 (1990-02-01), Itay
patent: 4909251 (1990-03-01), Seelich
patent: 4928603 (1990-05-01), Rose et al.
patent: 4952403 (1990-08-01), Vallee et al.
patent: RE33375 (1990-10-01), Luck et al.
patent: 4969880 (1990-11-01), Zamierowski
patent: 4983581 (1991-01-01), Antoniades et al.
patent: 5019559 (1991-05-01), Antoniades et al.
patent: 5023082 (1991-06-01), Friedman et al.
patent: 5030215 (1991-07-01), Morse et al.
patent: 5034375 (1991-07-01), Antoniades et al.
patent: 5035887 (1991-07-01), Antoniades et al.
patent: 5059123 (1991-10-01), Jernberg
patent: 5124155 (1992-06-01), Reich
patent: 5139527 (1992-08-01), Redl et al.
patent: 5171318 (1992-12-01), Gibson et al.
patent: 5171579 (1992-12-01), Ron et al.
patent: 5219328 (1993-06-01), Morse et al.
patent: 5226877 (1993-07-01), Epstein
patent: 5290552 (1994-03-01), Sierra et al.
patent: 5368858 (1994-11-01), Hunziker
patent: 5612456 (1997-03-01), Bishop et al.
patent: 554041 (1982-11-01), None
patent: 576365 (1985-12-01), None
patent: B-91093/91 (1992-06-01), None
patent: 1119516 (1982-09-01), None
patent: 1 168 982 (1984-12-01), None
patent: 3037270 (1982-05-01), None
patent: 231 987 (1986-01-01), None
patent: 0 081 990 (1983-06-01), None
patent: 0 312 208 (1988-09-01), None
patent: 0 341 007 (1989-11-01), None
patent: 0 443 724 (1991-08-01), None
patent: 0 562 864 (1993-09-01), None
patent: 1 584 080 (1977-12-01), None
patent: 2 041 942 (1979-02-01), None
patent: 2 042 556 (1979-02-01), None
patent: 2 102 811 (1983-02-01), None
patent: 2 137 209 (1984-10-01), None
patent: 2 102 811 (1985-01-01), None
patent: 2 185 747 (1987-07-01), None
patent: 55-110556 (1980-08-01), None
patent: 57-153645 (1982-09-01), None
patent: 58-38216 (1983-03-01), None
patent: 58-38217 (1983-03-01), None
patent: 59-192364 (1984-10-01), None
patent: 60-204725 (1985-10-01), None
patent: 63-24951 (1988-02-01), None
patent: 64-86974 (1989-03-01), None
patent: 1-99565 (1989-04-01), None
patent: 2-114 (1990-01-01), None
patent: 2-71750 (1990-03-01), None
patent: 2-167234 (1990-06-01), None
patent: 55-110557 (1990-08-01), None
patent: 81/00516 (1981-03-01), None
patent: 86/00526 (1986-01-01), None
patent: 86/01814 (1986-03-01), None
patent: 86/03122 (1986-06-01), None
patent: WO 88/03409 (1988-05-01), None
patent: WO 89/05656 (1989-06-01), None
patent: WO 89/11293 (1989-11-01), None
patent: WO 90/01331 (1990-02-01), None
patent: WO 91/00046 (1991-01-01), None
patent: WO 91/00046 (1991-01-01), None
patent: WO 91/00046 (1991-01-01), None
patent: 91/09573 (1991-07-01), None
patent: 91/17744 (1991-11-01), None
patent: 92/09697 (1992-06-01), None
patent: WO 92/09301 (1992-06-01), None
patent: WO 92/13547 (1992-08-01), None
patent: WO 92/13565 (1992-08-01), None
patent: 92/22312 (1992-12-01), None
patent: WO 93/05067 (1993-03-01), None
patent: WO 94/20133 (1994-09-01), None
patent: WO 96/17633 (1996-06-01), None
Berge, S.M., et al., “Pharmaceutical Salts,”J. Pharm. Sci. 66:1-19, American Pharmaceutical Association (1977).
Desai, S.J., et al., “Investigation of Factors Influencing Release of Solid Drug Dispersed in Inert Matrices,”J. Phar. Sci.54:1459-1464, American Pharmaceutical Association (1965).
Desai, S.J., et al., “Investigation of Factors Influencing Release of Solid Drug Dispersed in Inert Matrices II. Quantitaion of Procedures,”J. Pharm. Sci.55:1224-1229, American Pharmaceutical Association (1966).
Desai, S.J., et al., “Investigation of Factors Influencing Release of Solid Drug Dispersed in Inert Matrices III. Quantitative Studies Involving the Polyethylene Plastic Matrix,”J. Pharm. Sci.55:1230-1234, American Pharmaceutical Association (1966).
Desai, S.J., et al., “Investigation of Factors Influencing Release of Solid Drug Dispersed in Inert Matrices IV. Some Studies Involving the Polyvinyl Chloride Matrix,”J. Pharm. Sci.55:1235-1239, American Pharmaceutical Association (1966).
Higuchi, T., “Mechanism of Sustained-Action Medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices,”J. Pharm. Sci.52:1145-1149, American Pharmaceutical Association (1963).
McKay, I., and Leigh, I., “A1. Growth Factors,” inGrowth Factors: A Practical Approach, McKay, I., and Leigh, I., eds., Oxford University Press, New York, NY, pp. 237-243 (1993).
Pinholt, E.M., et al., “Bone Induction by Composites of Bioresorbable Carriers and Demineralized Bone in Rats: A Comparative Study of Fibrin-Collagen Paste, Fibrin Sealant, and Polyorthoester With Gentamicin,”J. Oral Maxillofac. Surg. 50:1300-1304, W.B. Saunders Co. (1992).
U.S. Appl. No. 08/328,552, filed on Oct. 25, 1994.
Genzyme Biotherapeutic Formulation & Delivery Research Report entitled “Research Report on TGF-β2 Formulated in Fibrin Glue” (dated Jun. 29, 1995).
Bowersox, J.C., Mission Plan of the Division of Military Trauma Research, Letterman Army Institute of Research, pp. 1-16 (Oct. 1992).
Hess, J.R., Draft of an animal use protocol (dated Oct. 10, 1991).
Larson, M.J., et al., “Efficacy of a Fibrin Hemostatic Bandage in Controlling Hemorrhage From Experimental Arterial Injuries,”Arch. Surg. 130:420-422, American Medical Association (Apr. 1995).
Hess, J., et al., “Hemorrhage Control With a Dry Powdered Thrombin and Fibrinogen Bandage,”Nederl. Milit. Geneesk 49:120-122, (Aug. 1996).
Holcomb, J., et al, “Efficacy of a Dry Fibrin Sealant Dressing for Hemorrhage Control After Ballistic Injury,”Arch. Surg. 133:32-35, American Medical Association, (1998).
Holcomb, J.B., et al., “New technologies for hemorrhage control,”Curr. Opin. Crit. Care 3:488-493, Rapid Science Publishers, (1997).
Holcomb, J.B., et al., “Effect of Dry Fibrin Sealant Dressings versus Gauze Packing on Blood Loss in Grade V Liver Injuries in Resuscitates Swine,”J. Trauma: Injury, Infection, Critica

Affiliated with

Also associated with

Rating

Methods for treating disease and forming a supplemented... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating disease and forming a supplemented..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating disease and forming a supplemented... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3750638